| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 65 |
| 1 | CRISABOROLE | 10 |
| 2 | TACROLIMUS | 4 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 4 |
| 4 | TACROLIMUS OINTMENT 0.1% | 4 |
| 5 | TRIAMCINOLONE ACETONIDE | 4 |
| 6 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 4 |
| 7 | ACETAMINOPHEN | 3 |
| 8 | PROPRANOLOL HYDROCHLORIDE | 3 |
| 9 | SPIRONOLACTONE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PRAZIQUANTEL | 1 | 0.0033 |
| 1 | CRISABOROLE | 10 | 0.0010 |
| 2 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | 2 | 0.0010 |
| 3 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND DEXTROMETHORPHAN HYDROBROMIDE | 2 | 0.0010 |
| 4 | ALBENDAZOLE | 1 | 0.0005 |
| 5 | ONASEMNOGENE ABEPARVOVEC-XIOI | 1 | 0.0004 |
| 6 | AZATHIOPRINE SODIUM | 1 | 0.0004 |
| 7 | ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE | 2 | 0.0003 |
| 8 | FLUOCINOLONE ACETONIDE | 1 | 0.0003 |
| 9 | DESONIDE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 65 |
| 1 | Phosphodiesterase 4 Inhibitor [EPC] | 10 |
| 2 | Corticosteroid [EPC] | 9 |
| 3 | Aldosterone Antagonist [EPC] | 3 |
| 4 | Anti-epileptic Agent [EPC] | 2 |
| 5 | Azole Antifungal [EPC] | 2 |
| 6 | Catecholamine [EPC] | 2 |
| 7 | Insulin Analog [EPC] | 2 |
| 8 | Kinase Inhibitor [EPC] | 2 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | Interleukin-4 Receptor alpha Antagonist [EPC] | 65 | 0.0001 |
| 2 | Anticholinergic [EPC] | 1 | 0.0001 |
| 3 | Phosphodiesterase 4 Inhibitor [EPC] | 10 | 0.0001 |
| 4 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 5 | Catecholamine [EPC] | 2 | 0.0000 |
| 6 | Insulin [EPC] | 1 | 0.0000 |
| 7 | Aldosterone Antagonist [EPC] | 3 | 0.0000 |
| 8 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 9 | Azole Antifungal [EPC] | 2 | 0.0000 |